title: Prostate cancer as a first and second cancer: effect of family history.
abstract: BACKGROUND
  Diagnosis with prostate cancer has been reported to increase the risk of subsequent tumours. However, specific data on individuals with a parental history are not available so far.
  
  
  METHODS
  On the basis of the nationwide Swedish Family-Cancer Database including 18,207 primary invasive prostate cancers, standardised incidence ratios (SIRs) were used to estimate the relative risks of subsequent tumours after prostate cancer in the general population and among individuals with a parental history of cancer.
  
  
  RESULTS
  A significantly increased SIR of colorectal cancer was found among prostate cancer patients with a parental history of colorectal cancer (2.26, 11 cases). The SIRs of parental concordant (same site) tumours after prostate cancer were also increased for urinary bladder cancer (4.42, 4 cases) and chronic lymphoid leukaemia (38.0, 2 cases).
  
  
  CONCLUSIONS
  A higher than additive and multiplicative interaction was observed between the individual history of prostate cancer and parental history of colorectal and urinary bladder cancers, although the number of cases did not permit the rejection of any interaction model. The results suggest that the occurrence of second tumours, for example bladder after prostate or prostate after bladder tumours, is mostly related to shared genetic and non-genetic risk factors rather than treatment of first cancer.
authors.affiliation: Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg 69120, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Zhang
authors.forename: J L
authors.initials: JL
authors.lastname: Bermejo
authors.forename: J
authors.initials: J
authors.lastname: Sundquist
authors.forename: K
authors.initials: K
authors.lastname: Hemminki
mesh_terms: D005190:Family; D006801:Humans; D008297:Male; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000235:genetics*; D012306:Risk; D001749:Urinary Bladder Neoplasms / Q000209:etiology / Q000235:genetics
references.citation: Acta Oncol. 2001;40(6):772-7
references.pmid: 11765074
references.citation: Nat Genet. 2008 Mar;40(3):310-5
references.pmid: 18264096
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):661-8
references.pmid: 16545920
references.citation: Prog Urol. 2007 Feb;17(1):35-40
references.pmid: 17373234
references.citation: IARC Sci Publ. 2004;(157):289-97
references.pmid: 15055302
references.citation: J Urol. 2008 Jan;179(1):91-5; discussion 95
references.pmid: 17997457
references.citation: J Urol. 1997 Jan;157(1):65-7
references.pmid: 8976217
references.citation: Eur J Cancer. 2007 Jul;43(11):1694-700
references.pmid: 17531466
references.citation: Cancer. 1997 Apr 15;79(8):1600-4
references.pmid: 9118045
references.citation: J Cell Biochem. 2006 Feb 15;97(3):433-47
references.pmid: 16267836
references.citation: J Urol. 2006 Feb;175(2):788-9; author reply 789
references.pmid: 16407052
references.citation: Int J Cancer. 2001 Jul 15;93(2):155-61
references.pmid: 11410860
references.citation: Thyroid. 2007 Dec;17(12):1277-88
references.pmid: 18020916
references.citation: Br J Cancer. 2005 Oct 3;93(7):838-41
references.pmid: 16136048
references.citation: Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):669-73
references.pmid: 16887293
references.citation: Gastroenterology. 2005 Apr;128(4):819-24
references.pmid: 15825064
references.citation: Arch Ophthalmol. 2005 May;123(5):601-4
references.pmid: 15883277
references.citation: J Urol. 2008 May;179(5 Suppl):S2-5
references.pmid: 18405742
references.citation: Leuk Res. 2005 Jan;29(1):59-61
references.pmid: 15541476
references.citation: N Engl J Med. 2008 Feb 28;358(9):910-9
references.pmid: 18199855
references.citation: Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):315-6
references.pmid: 10974441
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2020-6
references.pmid: 17057028
references.citation: Eur Urol. 2007 Oct;52(4):973-82
references.pmid: 17644245
references.citation: Nat Genet. 2008 Mar;40(3):281-3
references.pmid: 18264098
references.citation: J Natl Cancer Inst. 2005 Nov 2;97(21):1575-9
references.pmid: 16264177
references.citation: Cancer. 2006 Sep 1;107(5):991-8
references.pmid: 16878323
references.citation: J Natl Cancer Inst. 2006 Jan 4;98(1):15-25
references.pmid: 16391368
references.citation: Nat Genet. 2008 Mar;40(3):316-21
references.pmid: 18264097
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):637-9
references.pmid: 16751057
references.citation: Urol Int. 2005;75(3):213-6
references.pmid: 16215307
references.citation: Hered Cancer Clin Pract. 2006 Dec 15;4(4):186-92
references.pmid: 20223022